NECTIN4 and neoplasm: EV is an ADC targeting Nectin-4, consisting of a fully human monoclonal antibody against Nectin-4 and monomethyl auristatin E (MMAE), which induces cell cycle arrest and apoptosis, leading to tumor cell death [91].